 |
 |

COMMENTS AND OPINIONS
Conflicts of Interest Need to Be Reported Reliably
Jeff Whittle, MD, MPH
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
I was concerned to note that the Archives reported no financial conflicts of interest for Bertram Pitt, MD, in regard to his recent Invited Commentary1 to the article "Comparative Effectiveness of β-Blockers in Elderly Patients With Heart Failure."2
Dr Pitt's expertise in the area is obvious in his well reasoned and insightful commentary. However, it is clear that he has conflicts of interest in regard to the cardiovascular drugs in general and β-blockers in particular. For example, within the past month, he has disclosed his consulting relationship with Pfizer, Novartis, Takeda Pharmaceuticals North America, AstraZeneca, and Merck in the context of an article in the New England Journal of Medicine.3
The Archives has taken the principled position that an author's conflicts of interest should be disclosed to the reader. This seems especially important for editorials and invited commentaries. It is clear that Dr Pitt has . . . [Full Text of this Article] AUTHOR INFORMATION
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
Comparative Effectiveness of β-Blockers in Elderly Patients With Heart Failure—Invited Commentary
Bertram Pitt
Arch Intern Med. 2008;168(22):2431-2432.
EXTRACT
| FULL TEXT
RELATED LETTER
Conflicts of Interest Need to Be Reported Reliably—Reply
Bertram Pitt
Arch Intern Med. 2009;169(11):1079.
EXTRACT
| FULL TEXT
|